. 2023 Nov 16;8(47):45163. doi: 10.1021/acsomega.3c08464
Correction to “Discovery of a Novel Class of Dual GPBAR1 Agonists–RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders”
Bianca Fiorillo
, Rosalinda Roselli
, Claudia Finamore
, Michele Biagioli
✉, Cristina di Giorgio
, Martina Bordoni
, Paolo Conflitti
, Silvia Marchianò
, Rachele Bellini
, Pasquale Rapacciuolo
, Chiara Cassiano
, Vittorio Limongelli
, Valentina Sepe
✉, Bruno Catalanotti
, Stefano Fiorucci
, Angela Zampella
Bianca Fiorillo
Find articles by Bianca Fiorillo
Rosalinda Roselli
Find articles by Rosalinda Roselli
Claudia Finamore
Find articles by Claudia Finamore
Michele Biagioli
Find articles by Michele Biagioli
Cristina di Giorgio
Find articles by Cristina di Giorgio
Martina Bordoni
Find articles by Martina Bordoni
Paolo Conflitti
Find articles by Paolo Conflitti
Silvia Marchianò
Find articles by Silvia Marchianò
Rachele Bellini
Find articles by Rachele Bellini
Pasquale Rapacciuolo
Find articles by Pasquale Rapacciuolo
Chiara Cassiano
Find articles by Chiara Cassiano
Vittorio Limongelli
Find articles by Vittorio Limongelli
Valentina Sepe
Find articles by Valentina Sepe
Bruno Catalanotti
Find articles by Bruno Catalanotti
Stefano Fiorucci
Find articles by Stefano Fiorucci
Angela Zampella
Find articles by Angela Zampella
✉
Corresponding author.
Received 2023 Oct 26; Collection date 2023 Nov 28.
© 2023 The Authors. Published
by American
Chemical Society
Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/).
PMCID: PMC10688166 PMID: 38046314
This corrects the article "Discovery of a
Novel Class of Dual GPBAR1 Agonists–RORγt
Inverse Agonists for the Treatment of IL-17-Mediated Disorders" on page 5983.